Oncothermia: Complex therapy by EM and fractal physiology

Hyperthermia was the very first oncotherapy in human medicine. Despite its long history it has not achieved any breakthrough in clinical practices. The discovery of electromagnetism gave new hopes a century ago, however some controversies blocked its wide application. Oncothermia is a renewal, applying the synergy of the bioelectromagnetism with fractal physiology. Its basic approach makes selective energy absorption targeting the membrane rafts of the malignant cells. In this meaning this is a nanotechnology, treating the naturally present nano-particles (rafts) in 5 nm-range. The goal of the treatment is to induce apoptosis and drive the lost complex structure by possible re-synchronization of the autonomic malignant cells. The treatment tries avoid the constrains which induce unhelpful physiological reactions like the increase of the blood-flow which supports the tumor by nutrients and promotes metastatic processes. Oncothermia re-establishes the lost complexity of the malignant processes.